NFKB1 and neoplasm: The study64 also reported that ELF‐PEMF worked in sync with 2‐chloro‐N6‐(3‐iodobenzyl) adenosine‐5′‐N‐methyl‐uronamide (Cl‐IB‐MECA), an A3ARs agonist that could release the inhibition of tumor growth by the NF‐KB pathway to lead to tumor cell apoptosis,98 and finally induced G1 cell cycle arrest in tumor cells.64, 99